[Therapy of perioperative myocardial damage in aortocoronary venous bypass surgery].
The perioperative lesion of the myocardium in heart-lung machine operation can on principle not be prevented despite complex measures of the protection of the myocardium and the individual monitoring of the patients, this particularly by including patients with high risk of ischaemia of the myocardium (instable angina pectoris, stenosis of the trunc and greatly restricted left-ventricular function, respectively) in former years. In a proved perioperative lesion of the myocardium the limitation of the myocardial lesion stands in the centre of intensive-medical measures with vasodilators and positive inotropic substances.
Butzeck
J
J
Klinik für Anästhesie und Intensivtherapie, Humboldt-Universität zu Berlin.
Kothe
K
K
Porstmann
B
B
Aurisch
R
R
Hübner
R
R
D002303:Cardiac Output, Low / Q000517:prevention & control; D001026:Coronary Artery Bypass / Q000379:methods*; D003327:Coronary Disease / Q000601:surgery*; D004298:Dopamine / Q000008:administration & dosage; D004562:Electrocardiography / Q000187:drug effects; D004837:Epinephrine / Q000008:administration & dosage; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D005996:Nitroglycerin / Q000008:administration & dosage; D011183:Postoperative Complications / Q000517:prevention & control*; D012501:Saphenous Vein / Q000637:transplantation*; D014700:Verapamil / Q000008:administration & dosage
D014700:Verapamil; D005996:Nitroglycerin; D004298:Dopamine; D004837:Epinephrine
Therapie des perioperativen Myokardschadens bei aortokoronarer Venenbypass-Operation.